Stockreport

Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) [Seeking Alpha]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF MIRM's liver disease franchise underpins management's new $630–$650M sales guidance for FY 2026. Pipeline catalysts—volixibat (PSC/PBC), MRM-3379 (Fragile X), and bre [Read more]